| API SYNTHESIS AND MANUFACTURING |
Cynthia A. Challener
CDMOs have established strategies for handling new chemical entities with unknown biological activity. read more
| SOLID-DOSAGE DRUGS |
Milind K. Biyani
Capsules offer certain benefits over tablets for oral-solid dosage drugs, and several types of capsules are available. read more
Rita M. Steffenino
EMA and FDA guidance encourages design of drug products to improve patient compliance.
read more
| SINGLE-USE BIOREACTORS |
Paul Kubera
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
read more
| EXCIPIENTS |
Brian Carlin, George Collins, Linda A. Herzog, R. Christian Moreton, David R. Schoneker, Phyllis Walsh, Priscilla Zawislak, Joseph Zeleznik
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
read more
| FDA AUDITS |
Agnes Shanley
Just as FDA strengthens ties between reviewers and plant inspectors, proactive manufacturers are involving different disciplines in preparation for FDA audits.
read more
| ANALYTICS |
Heino Prinz
This article discusses fully automatic inspection of glass and plastic containers and factors that affect particle detection rate.
read more
| PROCESS OPERATIONS |
Agnes Shanley
Instead of rigidly applying statistical tools, experts suggest that pharma embrace statistical thinking, but focus on reducing variability and adding value for patients.
read more
| STATISTICAL SOLUTIONS |
Christopher Burgess
Is there a difference between a specification and a standard? read more
| PACKAGING |
Hallie Forcinio
Manufacturers introduce innovations in glass and plastic packaging for injectables. read more
| REGULATORY WATCH |
Jill Wechsler
Industry and FDA face new fee structures and new challenges in implementing fee initiatives.
read more
Sean Milmo
The European Commission is striving to tackle environmental pollution by pharmaceuticals as a means of curbing antimicrobial resistance.
read more
| OUTSOURCING OUTLOOK |
Jim Miller
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
read more
| ASK THE EXPERT |
Susan J. Schniepp
Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates. read more
| FROM THE EDITOR |
Rita C. Peters
Reeling from financial and tropical storms, Puerto Rico needs stable industry for recovery.
read more
|